Regen BioPharma Inc RGBP
$0.00
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
RGBP Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Regen BioPharma Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Regen BioPharma Inc. Stock Analysis RGBP
United States N/A Nano Cap Regen Biopharma, Inc. is a biotechnology company, which engages in the business of developing regenerative medical applications and advancing novel technologies through pre-clinical and Phase I and II clinical trials. The company is headquartered in La Mesa, California. The company went IPO on 2014-09-03. The firm is focused on developing treatments using autologous cell therapies, RNA and DNA-based immunotherapy and small molecules in the immune-oncology and autoimmune disease space. The firm is focused on novel technologies through pre-clinical and Phase I/ II clinical trials. Its primary program consists of identifying small molecules that inhibit or express NR2F6 to immune cell activation for oncology applications and immune cell suppression for autoimmune disease. The firm is also developing products treating blood disorders using small molecules and gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax, tCellVax, Dura-CAR), modulating key molecular processes in cancer stem cell through its patented molecular targeting approaches (BORIS), and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate).
Regen BioPharma Inc (RGBP) Chart
Financial Metrics & Statements of Regen BioPharma Inc (RGBP)
FAQ's for Regen BioPharma Inc (RGBP)
- As of August 2026, Regen BioPharma Inc RGBP is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Regen BioPharma Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Regen BioPharma Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Regen BioPharma Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Regen BioPharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Regen BioPharma Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Regen BioPharma Inc (RGBP)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
